SIGNALING MECHANISMS AND VASCULAR FUNCTION IN DIABETES MELLITUS

糖尿病的信号传导机制和血管功能

• 批准号: 7607390
• 负责人: MARK A CREAGER
• 金额: $ 1.59万
• 依托单位: BRIGHAM AND WOMEN'S HOSPITAL
• 依托单位国家: 美国
• 财政年份: 2007
• 资助国家: 美国
• 起止时间: 2007-04-01 至 2008-03-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/7607390
• 关键词: Blood Vessels; Computer Retrieval of Information on Scientific Projects Database; Diabetes Mellitus; Funding; Grant; Institution; Investigational Drugs; Learning; Purpose; Research; Research Personnel; Resources; Signal Transduction; Source; United States National Institutes of Health; ebselen; improved

This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. The purpose of this study is to learn how blood vessel function is altered by diabetes. They are studying an investigational drug, Ebselen, to see if it can improve the ability of blood vessels to widen. This is an investigator initiated study.

该子项目是利用该技术的众多研究子项目之一 资源由 NIH/NCRR 资助的中心拨款提供。子项目和 研究者 (PI) 可能已从 NIH 的另一个来源获得主要资金， 因此可以在其他 CRISP 条目中表示。列出的机构是 对于中心来说，它不一定是研究者的机构。 本研究的目的是了解糖尿病如何改变血管功能。 他们正在研究一种研究药物 Ebselen，看看它是否可以提高血管扩张的能力。 这是一项研究者发起的研究。